Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
2.55M
-
Shares change
-
+1.44M
-
Total reported value, excl. options
-
$28.1M
-
Value change
-
+$16.1M
-
Put/Call ratio
-
2.67
-
Number of buys
-
26
-
Number of sells
-
-10
-
Price
-
$11.02
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2019
41 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2019.
XBiotech Inc. - Common Shares, no par value (XBIT) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.55M shares
of 30.8M outstanding shares and own 8.27% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (723K shares), Balyasny Asset Management LLC (272K shares), Sofinnova Investments, Inc. (261K shares), MILLENNIUM MANAGEMENT LLC (212K shares), GEODE CAPITAL MANAGEMENT, LLC (166K shares), BlackRock Inc. (105K shares), EAM Investors, LLC (90.4K shares), GOLDMAN SACHS GROUP INC (81.3K shares), BARCLAYS PLC (79.5K shares), and Tibra Equities Europe Ltd (68K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.